Loading…

Prevalence of and risk factors for low bone mineral density in untreated HIV infection: a substudy of the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial

Objectives HIV infection is associated with a higher prevalence of low bone mineral density (BMD) and fractures than that found in the general population. There are limited data in HIV‐positive adults, naïve to antiretroviral therapy (ART), with which to estimate the relative contribution of untreat...

Full description

Saved in:
Bibliographic Details
Published in:HIV medicine 2015-04, Vol.16 (S1), p.137-146
Main Authors: Carr, A, Grund, B, Neuhaus, J, Schwartz, A, Bernardino, JI, White, D, Badel‐Faesen, S, Avihingsanon, A, Ensrud, K, Hoy, J
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Objectives HIV infection is associated with a higher prevalence of low bone mineral density (BMD) and fractures than that found in the general population. There are limited data in HIV‐positive adults, naïve to antiretroviral therapy (ART), with which to estimate the relative contribution of untreated HIV infection to bone loss. Methods The primary objective of the Strategic Timing of AntiRetroviral Treatment (START) Bone Mineral Density Substudy is to compare the effect of immediate versus deferred initial ART on bone. We evaluated traditional, demographic, HIV‐related and immunological factors for their associations with baseline hip and lumbar spine BMD, measured by dual‐energy X‐ray absorptiometry, using multiple regression. Results A total of 424 ART‐naïve participants were enrolled at 33 sites on six continents; the mean age was 34 years [standard deviation (SD) 10.1 years], 79.0% were nonwhite, 26.0% were women, and 12.5% had a body mass index (BMI) 
ISSN:1464-2662
1468-1293
DOI:10.1111/hiv.12242